Search research articles
Contact Us
Filters
Showing results (151-160 of 165) with videos related to
Page
of 17
Sort By:
The Journal of Dermatologic Surgery and Oncology
|
November 1, 1994
Flashlamp-pumped pulsed dye laser treatment of port-wine stains
R E Fitzpatrick, N J Lowe, M P Goldman, et al.
Journal of the American Academy of Dermatology
|
October 26, 2000
Tazarotene plus UVB phototherapy in the treatment of psoriasis
J Y Koo, N J Lowe, D A Lew-Kaya, et al.
The Journal of Investigative Dermatology
|
December 1, 1995
Low doses of repetitive ultraviolet A induce morphologic changes in human skin
N J Lowe, D P Meyers, J M Wieder, et al.
Journal of the American Academy of Dermatology
|
September 1, 1986
Effect of continued ultraviolet B phototherapy on the duration of remission of psoriasis: a randomized study
R S Stern, R B Armstrong, T F Anderson, et al.
Journal of the American Academy of Dermatology
|
November 1, 1996
Long-term low-dose cyclosporine therapy for severe psoriasis: effects on renal function and structure
N J Lowe, J M Wieder, A Rosenbach, et al.
Journal of the American Academy of Dermatology
|
December 1, 1991
A review of two controlled multicenter trials comparing 0.05% halobetasol propionate ointment to its vehicle in the treatment of chronic eczematous dermatoses
C A Guzzo, J S Weiss, H S Mogavero, et al.
Archives of Dermatology
|
February 5, 1998
The safety and efficacy of tazarotene gel, a topical acetylenic retinoid, in the treatment of psoriasis
G G Krueger, L A Drake, P M Elias, et al.
Archives of Dermatology
|
December 26, 2001
Tazarotene cream for the treatment of facial photodamage: a multicenter, investigator-masked, randomized, vehicle-controlled, parallel comparison of 0.01%, 0.025%, 0.05%, and 0.1% tazarotene creams with 0.05% tretinoin emollient cream applied once daily for 24 weeks
S Kang, J J Leyden, N J Lowe, et al.
Journal of the American Academy of Dermatology
|
July 1, 1997
Tazarotene gel, a new retinoid, for topical therapy of psoriasis: vehicle-controlled study of safety, efficacy, and duration of therapeutic effect
G D Weinstein, G G Krueger, N J Lowe, et al.
Journal of the American Academy of Dermatology
|
May 20, 1998
Once-daily tazarotene gel versus twice-daily fluocinonide cream in the treatment of plaque psoriasis
M Lebwohl, E Ast, J P Callen, et al.
Page
of 17
Search research articles
Search
Showing results (151-160 of 165) with videos related to
Sort By:
Page
of 17
The Journal of Dermatologic Surgery and Oncology
|
November 1, 1994
Flashlamp-pumped pulsed dye laser treatment of port-wine stains
R E Fitzpatrick, N J Lowe, M P Goldman, et al.
Journal of the American Academy of Dermatology
|
October 26, 2000
Tazarotene plus UVB phototherapy in the treatment of psoriasis
J Y Koo, N J Lowe, D A Lew-Kaya, et al.
The Journal of Investigative Dermatology
|
December 1, 1995
Low doses of repetitive ultraviolet A induce morphologic changes in human skin
N J Lowe, D P Meyers, J M Wieder, et al.
Journal of the American Academy of Dermatology
|
September 1, 1986
Effect of continued ultraviolet B phototherapy on the duration of remission of psoriasis: a randomized study
R S Stern, R B Armstrong, T F Anderson, et al.
Journal of the American Academy of Dermatology
|
November 1, 1996
Long-term low-dose cyclosporine therapy for severe psoriasis: effects on renal function and structure
N J Lowe, J M Wieder, A Rosenbach, et al.
Journal of the American Academy of Dermatology
|
December 1, 1991
A review of two controlled multicenter trials comparing 0.05% halobetasol propionate ointment to its vehicle in the treatment of chronic eczematous dermatoses
C A Guzzo, J S Weiss, H S Mogavero, et al.
Archives of Dermatology
|
February 5, 1998
The safety and efficacy of tazarotene gel, a topical acetylenic retinoid, in the treatment of psoriasis
G G Krueger, L A Drake, P M Elias, et al.
Archives of Dermatology
|
December 26, 2001
Tazarotene cream for the treatment of facial photodamage: a multicenter, investigator-masked, randomized, vehicle-controlled, parallel comparison of 0.01%, 0.025%, 0.05%, and 0.1% tazarotene creams with 0.05% tretinoin emollient cream applied once daily for 24 weeks
S Kang, J J Leyden, N J Lowe, et al.
Journal of the American Academy of Dermatology
|
July 1, 1997
Tazarotene gel, a new retinoid, for topical therapy of psoriasis: vehicle-controlled study of safety, efficacy, and duration of therapeutic effect
G D Weinstein, G G Krueger, N J Lowe, et al.
Journal of the American Academy of Dermatology
|
May 20, 1998
Once-daily tazarotene gel versus twice-daily fluocinonide cream in the treatment of plaque psoriasis
M Lebwohl, E Ast, J P Callen, et al.
Page
of 17